Literature DB >> 7296560

Commentary: current status of chemotherapy for non-small cell lung cancer.

J Aisner, H H Hansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7296560

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  14 in total

1.  Lung cancer: to treat or not to treat?

Authors:  M Goldberg
Journal:  Can Fam Physician       Date:  1985-06       Impact factor: 3.275

2.  Phase II study of (glycolate-O,O') diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer.

Authors:  M Fukuda; T Shinkai; K Eguchi; Y Sasaki; T Tamura; Y Ohe; A Kojima; F Oshita; K Hara; N Saijo
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  The benefit of cisplatin-based polychemotherapy for adenocarcinoma of the lung. The Kyushu Lung Cancer Chemotherapy Study Group.

Authors:  N Hara; M Ohta; Y Ichikawa; T Kanda; K Shima; K Tamura; M Hokama
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Complete remissions in non small cell lung cancer.

Authors:  J Klastersky; J P Sculier; P Mommen
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

Review 5.  Chemotherapy of advanced non-small cell lung cancer. A review.

Authors:  B J Takasugi; T P Miller
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

6.  Chemotherapy in non-small cell bronchial carcinoma.

Authors:  R Souhami
Journal:  Thorax       Date:  1985-09       Impact factor: 9.139

7.  Survival of patients with unresectable non-small cell lung cancer following 6,000 rad megavoltage radiotherapy.

Authors:  P P Kumar; R R Good; P R Hynes; S H Plantz; J E Somers; B E McAnulty; G F McCaul; S S Rogers; M A Reeves
Journal:  J Natl Med Assoc       Date:  1987-03       Impact factor: 1.798

8.  Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.

Authors:  P Drings; U Abel; H Bülzebruck; P Stiefel; M Kleckow; H G Manke
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.

Authors:  R Stuart-Harris; R M Fox; D Raghavan; A S Coates; D Hedley; J A Levi; R L Woods; M H Tattersall
Journal:  Thorax       Date:  1985-05       Impact factor: 9.139

10.  Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores.

Authors:  N Mackworth; P Fobair; M D Prados
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.